Rabeena Fazal MD in Brooklyn, New York

Home New York Brooklyn

Rabeena Fazal MD has Nephrology as her primary medical specialty. Their primary office is: 443 Linden Blvd in Brooklyn, New York. There is an additional office location, for a total of two, for Rabeena Fazal MD that can be viewed further down. They attended Icahn School Of Medicine At Mount Sinai and graduated in 2002 (around 22 years of experience). They are listed as doing telehealth appointments.

Rabeena Fazal MD Office Phone and Directions

Rabeena Fazal MD
443 Linden Blvd
Brooklyn, New York 11203
718-785-9239

Patient Ratings
Please rate your experience with Rabeena Fazal MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 718-785-9239

Enter a starting address:

Healthcare Info for Rabeena Fazal MD

Medical School: Icahn School Of Medicine At Mount Sinai
Graduation Year: 2002
The Primary Medical Specialty for Rabeena Fazal MD is listed as: Nephrology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 22
PAC (PECOS ID)#: 3274556121
NPI #: 1750394391
NPI Created On: 08/14/2006
NPI Last Updated Listed as: 12/23/2013
Primary Taxonomy Code: 207R00000X
License Number:
237316
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 850015243

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Gastroenterology

Name of Drug #1: XIFAXAN

Open Associated Drug #1: 65649-303-02